Donald A. Bergstrom, President, R&D at Relay Therapeutics, Inc. (RLAY), sold 61,794 shares at $7.29 ($450K) on 2025-10-28, disclosed to the SEC on 2025-10-30.
Open-market sale of $450k RLAY by President, R&D. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.29 | 30,897 | $225K | 50.0% |
| 2 | $7.29 | 30,897 | $225K | 50.0% |
| Total | $7.29 avg | 61,794 | $450K | 100% |
| Filing → |
| RLAY | SELL | 2026-07-08 | $162K | — | Filing → |
| RLAY | SELL | 2026-06-24 | $1.6M | — | Filing → |
| RLAY | SELL | 2026-04-30 | $22K | — | Filing → |